Abstract: Functional disturbance in the novel adenylyl cyclase signaling mechanism (ACSM) of insulin and relaxin action in rat streptozotocin (STZ) type I diabetes was studied on the basis of the authors' conception of molecular defects in hormonal signaling systems as the main causes of endocrine diseases. Studying the functional state of molecular components of the ACSM and the mechanism as a whole, the following changes were found in the skeletal muscles of diabetic rats compared with control animals: 1) increase of insulin receptor binding due to an increase in the number of insulin binding sites with high and low affinity; 2) increase of the basal adenylyl cyclase (AC) activity and the reduction of AC-activating effect of non-hormonal agents (guanine nucleotides, sodium fluoride, forskolin); 3) reduction of ACSM response to stimulatory action of insulin and relaxin; 4) decrease of the insulin-activating effect on the key enzymes of carbohydrate metabolism, glycogen synthase and glucose-6-phosphate dehydrogenase. Hence, the functional activity of GTP-binding protein of stimulatory type, AC and their functional coupling are decreased during experimental type 1 diabetes that leads to the impairment of the transduction of insulin and relaxin signals via ACSM. c Versita Warsaw and Springer-Verlag Berlin Heidelberg. All rights reserved. 
Introduction
One of the urgent problems in contemporary molecular endocrinology is the study of the signaling mechanisms of the pleiotropic regulatory action of insulin and related peptides in normal organisms and their dysregulation in the case of diabetes. In this paper, the results of a study of functional defects in the adenylyl cyclase (AC) signaling mechanisms of two classes of hormones in type 1 diabetes are presented: (i) insulin and relaxin, belonging to the insulin superfamily, and (ii ) catecholamines.
A new approach was used to study the diabetes, which is based on the original conceptual and experimental work carried out in our laboratory. This includes firstly molecular defects in the hormonal signaling systems as the key causes of endocrine diseases [1] ; and, secondly, the discovery of a novel, adenylyl cyclase signaling mechanism (ACSM) of insulin and relaxin action in rat skeletal muscles [2] [3] [4] [5] [6] [7] .
The present study is devoted to functional state of the ACSM in experimental streptozotocin (STZ) type 1 diabetes in rat. According to our previous findings, the structuralfunctional organization of ACSM of insulin can be described as the following signaling cascade: receptor-tyrosine kinase → G protein of inhibitory type (G i -protein) (Gβγ-dimer) → phosphatidylinositol 3-kinase → protein kinase Cζ → G protein of stimulatory type (G s protein) → AC ( Figure 1 ). Relaxin-induced ACSM has a similar signal transduction organization at the post-receptor stages [4, 7] . There is, however, one difference concerning the relaxin receptor. Whether the nature of the relaxin receptor is of serpentine or tyrosine kinase type remains unresolved.
Some relaxin receptors of the serpentine type have been detected and cloned [8, 9] . However, there are data in favor of the existence of tyrosine kinase type relaxin receptors (such that tyrosine kinase blockers posses an inhibitory action on relaxin signaling) [4, 5, 10, 11] . This allowed us to hypothesize the presence of both types of relaxin receptors, possibly scattered in different target tissue. This hypothesis was to some extent confirmed in our study with the synthetic peptides corresponding to 619-629 and 615-629 amino acid residues of the C-terminal region of the third intracellular loop of the relaxin receptor LGR7 [12] . This type of receptor was identified in rat brain and rat cardiac muscles, but was not detected in rat skeletal muscles and muscles of invertebrates (i.e. mollusk) in spite of relaxin AC activating effect in all these tissues is observed.
To determine the hormone specificity of defects in insulin and relaxin ACSM in STZinduced type I diabetes, a comparative study has been carried out on the functional state of AC systems that are sensitive to catecholamines and consisting of three components: serpentine type receptor, heterotrimeric G protein, and AC ( Figure 1 ). Fig. 1 The structural-functional organization of insulin and catecholamine adenylyl cyclase signaling system in rat skeletal muscles. AC, adenylyl cyclase; G i βγ, βγ-dimer of heterotrimeric G-protein of inhibitory type; G s , heterotrimeric G-protein of stimulatory type; PI-3-K, phosphatidylinositol 3-kinase; PKCζ, protein kinase Cζ.
At present, data is available on the functional disturbance in some components of the insulin signaling system in diabetes, obesity, and insulin resistance of peripheral tissues [13, 14] . But the information on the functional state of the hormonal signaling system as a whole (including the stage of second messenger formation) in such pathologies as diabetes, obesity, and insulin resistance is scant.
The present work was undertaken with the aim to: (1) study the functional state of the novel ACSM of insulin and relaxin action and some of its components in the skeletal muscle of rat with experimental STZ type 1 diabetes; (2) study, under the same conditions, the functional state of catecholamine AC signaling with respect to testing the specificity of diabetes influence on ACSM of insulin nature hormones; and (3) study the influence of insulin on the activity of the two key enzymes of carbohydrate metabolism, such as glycogen synthase (GS) and glucose-6-phosphate dehydrogenase (G6PDH), in the skeletal muscles of rats with STZ diabetes, taking into account the tissue insulin resistance in diabetic organism.
Experimental Procedures

STZ-induced type I diabetes model
Four groups of male rats Rattus norvegicus (weight 120-150 g) were used: (1) control, (2) with insulin injection (the same groups were studied under relaxin and isoproterenol injection conditions), (3) diabetic rats, (4) diabetic rats with insulin treatment. The experimental diabetes was induced by intraperitonial injection of STZ (65 mg/kg body weight). The control group was injected with the physiological solution. The rats treated with STZ had stable glucosuria detected with diagnostic test "GlukoPHAN" and hyperglycemia. The blood glucose level, determined by o-toluidine method, was increased by two to four fold. The study was carried out with respect to the dynamics of diabetes development -acute (one day) and chronic (7, 10 and 30 days).
The sarcolemma membrane fraction was isolated from the leg skeletal muscles (for each fraction 4-6 rats were used) according to the method of Kidwai et al. (1973) [15] , with some modifications [6] , and was used for determination of AC activity and GTPbinding activity of G proteins. 
Chemicals and radiochemicals
Insulin binding of rat skeletal muscle membranes
The insulin receptor binding was determined by competition displacement of labeled [ 125 I]insulin (of pig) with the non-labeled hormone as described earlier [16] . The radioactivity of the precipitate was measured by a γ-counter. The data obtained was analyzed using the Scatchard method.
Adenylyl cyclase assay
AC (EC 4.6.1.1) activity was measured in muscle membrane fractions by the method of Salomon et al. (1974) [17] , with some modifications [6] . The reaction mixture (final volume 50 μl) contained 50 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 , 0.1 mM ATP, 1 mM cAMP, 20 mM creatine phosphate, 0.2 mg/ml creatine phosphokinase, 1 μCi [α−
32 P]ATP and 15-20 μg of membrane protein. Incubation was carried out at 37
• C for 3 min (for insulin and relaxin) or 10 min (for isoproterenol). cAMP was determined using alumina or aluminum oxide, Al 2 O 3 , for column chromatography. Each assay was carried out in triplicate from at least three independent samples and the results were expressed as pmol cAMP/min per mg of membrane protein.
GTP-binding of G proteins
The GTP-binding of G proteins in rat muscle membranes was measured using the methods of Panchenko et al. (1987) [18] and McIntire et al. (2001) [19] , with some modifications [20] . The GTP-binding assay was carried out at 4
• C for 10 min in 25 mM HEPES-Na buffer (pH 7.4), contained 100 mM NaCl, 1mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 0.1% BSA, 10 −6 M β,γ-imidoguanosine 5'-triphosphate (GppNHp) and 0.5-1.0 μCi 
Conditions of experiments
The effects of hormones (in vivo and in vitro) and non-hormonal activators of AC (in vitro) were studied. The dose of insulin in vivo (i.p.) was 90 ng/g of body weight. Experiments in vitro were carried out by adding the hormones and non-hormonal AC activators to the samples for enzyme activity determination. In the control series, the corresponding solvents were added.
For the in vitro study of the functional state of AC signaling system as a whole, and its separate molecular components, the following reagents were used: hormones (insulin, relaxin and isoproterenol), which start up the whole AC signaling chain; GppNHp as an agent revealing the G s protein AC stimulating function, as well as the combined action of hormone and GppNHp, reflecting the functional coupling in the whole signaling chain (from receptor to G s protein and AC); NaF-inducing activation of G s protein and as a consequence of AC; and forskolin, revealing the catalytic function of AC.
Activity of enzymes of carbohydrate metabolism
The study of the activities of GS and G6PDH (both cytosol proteins) was carried out using the supernatant of muscle tissues (centrifugation, 1800 g, 10 min). Of in vivo experiments, the tissue was homogenized in the 0.25 M sucrose solution containing 60 mM NaF (for GS) and in the 0.15 M KCl solution (for G6PDH). Of in vitro experiments, 12 mM Tris-HCl buffer (pH 7.4) was used. The determination of GS and G6PDH activities was developed by the methods of Barber et al. (1967) [21] and Stanton et al. (1991) [22], correspondingly. G6PDH activity was expressed as μmoles NADPH/min per mg of protein. GS activity was given as activity of independent (active) form of enzyme (GS-I) (in the absence of glucose 6-phosphate) in percentage or in μmoles NAD/10 min per mg of protein.
Data analysis
The data is presented as the mean ± SEM for three individual experiments. Each point represents the mean of triplicate values. Differences between control and hormonal or nonhormonal agent-treated groups were statistically assessed using ANOVA and considered significant at p < 0.05.
Results
Experimental streptozotocin (STZ) diabetes
3.1.1 The sensitivity of adenylyl cyclase signaling system to hormonal and non-hormonal agents in skeletal muscles of diabetic rats
It is commonly accepted that STZ-induced form of diabetes in the rat is a good model to study the human type 1 diabetes characterized by insulin deficiency and insulin resistance of the target-tissues. In our experiments, acute (one day) and chronic (7, 10 and 30 days) forms of insulin deficiency were induced in the rats with one injection of STZ (see Experimental Procedures). Acute and chronic diabetes was accompanied by hyperglycemia (the glucose level in blood increased roughly two to four fold). As shown in our study, the insulin binding capacity of the receptors in the skeletal muscles of STZ diabetic rats significantly increases due to the increase in receptor number with high and low affinity to the hormone (Table 1) . Our data concerning the characteristics of insulin receptor are in agreement with that obtained by the same method in rat skeletal muscles [23, 24] . It allows us to conclude that functional disturbance in insulin-competent ACSM should not be ascribed to the decreasing of insulin receptor activity. In the AC system of STZ treated rats, as compared with control animals, the following changes were observed (Tables 2 and 3 ): (i) the increase of basal AC activity; (ii ) considerable decrease of AC sensitivity to non-hormonal activators (NaF, GppNHp and forskolin); (iii ) the decrease of AC system reactivity to the peptide hormones insulin and relaxin (in vitro, 10 −8 M) without, or in the presence of, GppNHp (10 −6 M);
(d) the lowering of GTP-binding activity of G proteins; and finally, (iv ) the decrease of the stimulating effects of insulin superfamily peptides on GTP-binding activity. These findings show that, in the skeletal muscles of diabetic rats, the insulin and relaxin signal transduction via ACSM is disturbed. Figures in parentheses represent the increase of NaF-, GppNHp-, forskolin-and hormone-stimulated AC activity (in percentage) over the basal AC activity (set at 100 %) of corresponding group of animals. Values are expressed as the mean ± SEM for four individual experiments (p<0.05).
Isoproterenol (10 −5 M), specific agonist of β-adrenergic receptors, stimulates the AC activity in the muscles of both control and STZ diabetic rats. However, the AC stimulat-ing effect of isoproterenol and the GppNHp potentiating influence on the isoproterenolinduced effect are lower in the STZ animals ( Table 2 ). Isoproterenol stimulation of GTPbinding activity of G proteins (preferably G s -proteins) in STZ rats, compared to control, is weaker (Table 3 ). It appears that the reactivity of G s protein-AC system to isoproterenol in the skeletal muscles of diabetic rats is reduced. The AC signaling mechanisms comparative study employing different natural hormones (insulin, relaxin and catecholamines) in insulin-dependent diabetes gives evidence for the first time in favor of the damage in the same signaling components: G s -protein, AC, and in their coupling.
To test the supposition that insulin deficiency was directly responsible for functional defects detected in the insulin-competent ACSM, the experiment was performed in vivo with ten-day insulin therapy of STZ diabetic rats. Insulin was injected during the last five days at a dose of 90 ng/g body weight twice a day. The injection led to the decrease of glucose levels close to the control values. AC activity in ten-day insulin-treated STZ rats was 7.0 ± 0.65 pmol cAMP/min per mg of membrane protein and was effectively stimulated in vitro by insulin (+126 %). The data obtained shows that even five-day insulin injection leads to a considerable decreasing of hyperglycemia and to the restoration of ACSM insulin reactivity. activity in skeletal muscles of control animals (Fig. 2) . The maximal effect is produced at insulin concentration 10 −9 M. In one, 7 and 30-days diabetic animals, hormone effect on GS activity is below that for the control animals. The dose-dependence of insulin on GS has not been observed on the first and the seventh days of diabetes (Fig. 2) . This suggests that STZ diabetes leads to the decreasing of the insulin regulatory action on the GS activity. The injection of insulin in vivo (0.05-10 ng/g of body weight, 15 min) in the control rats leads to an increase of the the GS activity in the skeletal muscles. The activating effect of insulin is found to be dose-dependent, reaching the maximum at dose 0.05-0.1 ng/g of body weight and decreases as the insulin dose further increases. With the development of STZ diabetes (one to 30 days), the activating influence of insulin is practically vanished (data not given).
The similar picture is observed in the case of glucose-6-phosphate dehydrogenase (G6PDH), the key enzyme of pentose phosphate pathway. In vitro, the dose-response curve of insulin (10 −11 -10 −7 M, 30 min) on G6PDH activity in the skeletal muscles of 30-day STZ diabetic rats is below that of control animals ( Fig. 3) and the dose-dependence of insulin on the enzyme activity is practically lacking. In vivo, no stimulating effect of insulin (90 ng/g of body weight, 30 min) on G6PDH activity is observed in the skeletal muscles of rats at any stage of diabetes development (data not given). The above data on GS and G6PDH suggest a considerable decrease of the insulin regulatory effect on the activity of the two key enzymes of carbohydrate metabolism in the skeletal muscles of STZ diabetic rats. Fig. 3 The influence of insulin in vitro on G6PDH activity in the skeletal muscles of control and 30-day STZ diabetic rats. Horizontal axis --log[insulin], M; vertical axis -G6PDH activity (μmol NADPH/min per mg of protein). 1 -control rats, 2 -STZ rats. The enzyme activity was determined in the supernatant of rat muscle extracts (centrifugation, 1800 g, 10 min) in 12 mM Tris-HCl buffer (pH 7.4). Insulin was added to the samples (duration of hormone action is 30 min, 25
• C).
Discussion
The study of the functional state of insulin signal transduction systems involving ACSM in the skeletal muscles of rats with experimental STZ diabetes was undertaken. In the condition of hyperglycemia and glucosuria, in the muscles of rats (one, 7 and 30 days of diabetes) there is the increase in AC basal activity and the decrease of AC sensitivity to non-hormonal agents (NaF, GppNHp and forskolin). In the in vitro experiments with of insulin and relaxin action, the sensitivity of ACSM to both hormones is decreased and the potentiating effect of guanine nucleotides on hormonal signal transduction practically disappears. According to our data, in the case of insulin, this is not connected with the reduction of insulin receptor functions. STZ-induced diabetes, on the contrary, enhances insulin binding, likely to be a compensatory reaction to insulin deficiency. Functional defects in insulin-and relaxin-competent ACSMs, as has been shown, appear at the later (distal) stages of hormonal signal transduction (the G s -protein and AC components). One of the possible causes underlying the disturbance of ACSM function in diabetes is an increase in AC basal activity. As a result, the catalytic potency of the enzyme is limited, leading to the reduction of its response to the hormonal stimulus. Such a view finds support in the fact that in the diabetic muscles in our study, the AC stimulating effect of forskolin, directly responsible for activation of catalytic function of the enzyme, is decreased. An increase in AC basal activity in STZ diabetes was found in the rat liver [25] and in the adrenal gland of diabetic rats due to overexpression of different isoforms of the enzyme [26] . Another cause of dysfunction in the insulin-and relaxin-competent ACSM in the skeletal muscles of STZ diabetic rats may be the weakening of G s -protein function and the ability of the protein to interact with AC. This is supported by the decrease of the effects of G protein activators NaF and guanine nucleotides (GppNHp), and a suppression of GppNHp potentiating influence on the hormone effects. The decrease (about 50 %) of the GppNHp stimulating effect on AC in the myocardium of diabetic rats was described earlier [27] . In the present study, isoproterenol stimulation of GTPbinding of heterotrimeric G proteins in the STZ diabetes model is reduced in the skeletal muscles, and in the heart muscle of rats [28] .
Insulin deficiency developing in type 1 diabetes may be the primary causal factor of dysfunction of insulin signal transduction (in our case in ACSM). This is confirmed in the present study whereby five-day insulin therapy restores to control the insulin-induced AC acitivty of ten-day STZ diabetic rats.
There seems to be evidence suggesting that insulin, in a normal organism, is an important factor or for the maintenance in the functionally active state of both ACSM of insulin action (self-regulation) and AC-dependent signaling mechanisms of other hormones. A similar idea about the influence of insulin on its own signaling mechanisms, via modulation of their signaling components, has been put forward by others [14] .
An important role in the disturbance of ACSM of insulin action may be ascribed to hyperglycemia that arises as a result of insulin deficiency, which is characteristic of type 1 diabetes. Hyperglycemia was shown to modulate functional activity of some components of insulin-competent signaling systems in diabetes including AC signaling system [14, 29, 30] , decreasing the activity of down-stream signaling links of systems such as protein kinase B, glycogen synthase, and others. The following chain of events causing a dysregulation of insulin signal transduction in type 1 diabetes has been suggested: the decrease of blood insulin level (⇓) (as a result of insulin deficiency) → hyperglycemia (⇑) → diacylglycerol (⇑) → protein kinase C (⇑) [31] . Analyzing the functional disturbances in the insulin-competent ACSM in the diabetic muscle tissues, the results of our previous investigation [6] showing that activation of protein kinase C with phorbol esters or diacylglycerol leads to negative regulation of the insulin-induced AC signaling cascade should be taken into account. According to the scientific literature and our data, such protein kinase C-dependent regulation affects G s -protein by inducing serine/threonine phosphorylation and in this way, decreasing its signal transduction function.
The functional changes in the insulin signaling system we found in the skeletal muscles of STZ diabetic rats are similar to that in the myocardium of these animals [24, 28, 32] . In particular, in the myocardium of diabetic rats, the following events were observed: an increase in insulin receptor number, increase in insulin-induced phosphorylation of insulin receptor and its substrates (IRS1-and IRS2-proteins), and stimulation of PI-3K activity. At the same time, there was a reduction in insulin-induced phosphorylation of the GS kinase-3 and in stimulation of the GS activity. This is in good agreement with our study, showing the suppression of insulin regulation of the GS activity in the skeletal muscles of diabetic rats (Fig. 2) .
The causes underlying the changes of insulin signaling functions in the skeletal muscle and the myocardium muscle in insulin-dependent diabetes seems to be the same. The proximal signaling proteins (insulin receptor, IRS-proteins, PI-3K) show increased activity, whereas the functions of distal signaling components become less active [24] . We have also obtained evidence for an increase in insulin receptor function and the rather poor reaction of the distal signaling components of ACSM (G s -protein and AC) to insulin. These opposing changes lead to dysfunction of the whole process of insulin signal transduction via the AC signaling cascade. Wang et al. (1999) [32] proposed that amplification of the first stages of insulin signal transduction is due to insulin deficiency, while function decrease of the distal stages (including the enzymes of carbohydrate metabolism) is due to hyperglycemia.
Concerning the reason for dysfunction of relaxin-competent ACSM in skeletal muscles of STZ diabetic rats, we have revealed that they are the same as in ACSM of insulin; that is, the damage in the common downstream blocks G s -protein, AC and their coupling. Regarding the functional state of the relaxin receptor in diabetic conditions we have not found any information. In this respect, there is special interest in the data of Olefsky et al. (1982) [33] . In this study, they had detected the relaxin stimulating effect on insulin receptor ligand affinity, which led to the increase of insulin regulatory action on glucose metabolism in adipocytes of normal rats. These findings point to evidence for a functional interaction between relaxin and insulin at the receptor level. This relaxin potentiating effect may be transmitted via postreceptor signaling (in particular via ACSM -common for relaxin and insulin) to the targets of insulin regulatory action.
The study of the influence of STZ-induced insulin deficiency on insulin regulation of carbohydrate metabolism enzymes in the rat skeletal muscles shows the decrease of their insulin reactivity. This is manifested as the decrease or even disappearance of the insulin-activating effects on GS and G6PDH. As mentioned above, in STZ diabetes the functions of distal components of the insulin signaling chain leading to GS activation are decreased [14] .
Concerning G6PDH, Berg et al. (1995) have demonstrated that the increasing enzyme activity is due to the enhancement of its expression in the liver of normal rats under the action of insulin [34] . At the same time, STZ diabetes (18 days) leads to the decrease of G6PDH activity. The insulin therapy of diabetic rats returns the enzyme activity to control levels.
The functional state of G6PDH, as shown, depends to a great extent on the level of glycemia [35] . In diabetes, inhibition of G6PDH activity is provoked by elevation of glucose levels leading to an increase of the basal AC activity and to the activation of protein kinase A. The latter phosphorylates G6PDH thereby inducing its inhibition [35] . In view of the fact that hyperglycemia is characteristic of the type 1 diabetes, it seems reasonable to suggest that in STZ diabetes (in the present study) a similar mechanism takes place.
In conclusion, experimentally-induced insulin deficiency in the rats manifests in the skeletal muscles by a disturbance of the insulin/relaxin and catecholamine signal trans-duction via AC signaling mechanism on the common stage of G s -protein and its coupling with AC, as well as by the decrease of some carbohydrate metabolism enzymes involved in insulin reactivity.
